Solid-State Reaction in Zinc Alkoxide Single Crystals
1.909 mmol) in THF (2 mL). After 5 min of stirring, 172 of µL
t-BuOH (1.909 mmol) was added via a syringe to the yellow
solution. The resulting pale yellow-green solution was stirred for
an extra 90 min and then concentrated down to 1-2 mL.
[(3Ph-sal)Zn(µ-OtBu)]2 (1c). The complex 1c was prepared
according to the general procedure (77%). Anal. Calcd for (C20H25-
NO2Zn)2: C, 63.75; H, 6.69; N, 3.72. Found: C, 63.78; H, 6.64;
N, 3.91. 1H NMR (CD2Cl2, 300 MHz): δ 1.09 (s, 18H, C(CH3)3),
1.49 (d, J ) 6.54 Hz, 12H, CH(CH3)2), 3.72 (sept, J ) 6.54 Hz,
2H, CH(CH3)2), 6.64 (“t”, J ) 7.5 Hz, 2H, aryl-H), 7.12 (dd, J )
7.78, 1.87 Hz, 2H, aryl-H), 7.29-7.35 (m, 6H, Ph-H), 7.47 (dd, J
) 7.47, 1.87 Hz, 2H, aryl-H), 7.7-7.8 (m, 4H, Ph-H), 8.29 (s, 2H,
aldimine-H). 13C NMR (CD2Cl2, 75.45 MHz): δ 24.95, 33.41,
63.60, 71.42, 114.22, 118.95, 126.50, 127.86, 127.93, 130.05,
134.24, 135.37, 135.99, 140.09, 168.86, 169.52.
[(3Me-sal)Zn(µ-OtBu)]2 (1a). The resulting pale yellow-green
solution was stirred for an additional 90 min and then concentrated
down to 1-2 mL. Approximately 2 mL of hexane was added, and
the solution was then placed at -20 °C. Pale yellow crystals formed
after 2 days. The supernatant liquor was removed, and the crystals
were dried under vacuum and collected to yield 405 mg (68%).
Anal. Calcd for (C15H23NO2Zn)2: C, 57.24; H, 7.37; N, 4.45.
Found: C, 56.98; H, 7.23; N, 4.73. 1H NMR (C6D6, 300 MHz): δ
1.26 (d, J ) 6.54 Hz, 12H, CH(CH3)2), 1.41 (s, 18H, C(CH3)3),
2.50 (s, 6H, 3-CH3), 3.08 (sept, 2H, J ) 6.54 Hz, CH(CH3)2), 6.5-
6.65 (m, 2H, aryl-H), 6.8-6.9 (m, 2H, aryl-H), 7.2-7.3 (m, 2H,
aryl-H), 7.78 (s, 2H, aldimine-H). 13C NMR (C6D6, 75.45 MHz):
δ 17.18, 24.70, 33.50, 63.04, 71.50, 113.84, 116.74, 132.01, 133.82,
135.24, 169.27. X-ray analysis of the crystals revealed that the
complex exists as a µ-t-butoxide-bridged dimer in the solid state.
(3Me-sal)Zn(µ-OtBu)]2‚2Toluene (1a‚2Toluene). To a solution
of zinc bis(trimethylsilyl)amide (0.90 mL, 2.23 mmol) in toluene
(8 mL) was added a solution of the 3-methylsalicylaldimine 1 (395
mg, 2.23 mmol) in toluene (2 mL). After 5 min of stirring, 213 µL
of t-BuOH (2.32 mmol) was added via a syringe to the yellow
solution. The resulting pale yellow-green solution was stirred for
an additional 90 min and then concentrated down to 1-2 mL. The
solution was then placed at -20 °C. Colorless block-shaped crystals
formed after several days. The supernatant liquid was removed,
and the crystals were dried under an argon flow at -30 °C for 60
min (59%). Anal. Calcd for (C22H31NO2Zn)2: C, 64.94; H, 7.68;
[(3iPr-sal)Zn(µ-OtBu)]2‚thf (1d‚thf). The complex 1d‚thf was
prepared according to the general procedure (50%). Anal. Calcd
for (C34H54NO2Zn)2: C, 59.57; H, 7.94; N, 4.09. Found: C, 59.51;
H, 7.99; N, 4.01. 1H NMR (C6D6, 300 MHz): δ 1.25 (d, J ) 6.53
Hz, 12H, CH(CH3)2), 1.37 (d, J ) 6.84 Hz, 12H, NCH(CH3)2),
1.42 (s, 18H, C(CH3)3), 3.10 (sept, J ) 6.53 Hz, 2H, CH(CH3)2),
3.98 (sept, J ) 6.84 Hz, 2H, NCH(CH3)2), 6.67 (“t”, J ) 7.47 Hz,
2H, aryl-5H), 6.87 (dd, J ) 8.09, 1.87 Hz, 2H, aryl-4H), 7.34 (dd,
2H, J ) 7.16, 1.87 Hz, aryl-6H), 7.77 (s, 2H, aldimine-H). 13C
NMR (C6D6, 75.45 MHz): δ 23.06, 24.86, 27.07, 33.79, 63.05,
71.52, 114.17, 117.22, 131.18, 133.74, 142.39, 169.31. IR (KBr):
ν˜ ) 3425 (w), 2972, 1621, 1547, 1458, 1410 (s), 1368, 1326, 1288,
1259, 1231 (w), 1208, 1146 (m), 1104, 1052, 1019, 986 (w), 934
(m), 892, 854, 835, 807 (w), 750 (s), 712, 627, 590, 566, 529 (w)
cm-1. Block-shaped, slightly yellow crystals suitable for X-ray
analysis were obtained at -20 °C from THF/hexane after 2 days.
The X-ray analysis revealed that the complex exists as a µ-t-
butoxide-bridged dimer with one molecule of THF in the solid state.
[(5Nitrosal)Zn(µ-OtBu)]2‚Toluene (1e‚Toluene). The complex
1e‚toluene was prepared in toluene according to the general
procedure (77%). Anal. Calcd for (C14H20N2O4Zn)2‚(C7H8): C,
1
N, 3.44. Found: C, 60.97; H, 6.99; N, 3.92. H NMR (C6D6, 200
MHz): δ 1.25 (d, J ) 6.64 Hz, 12H, CH(CH3)2), 1.40 (s, 18H,
C(CH3)3), 2.11 (s, 3H, CH3-toluene), 2.50 (s, 6H, 3-CH3), 3.08 (sept,
J ) 6.64 Hz, 2H, CH(CH3)2), 6.58 (“t”, J ) 7.85 Hz, 2H, aryl-H),
6.86 (dd, J ) 7.85, 1.66 Hz, 2H, aryl-H), 6.95-7.2 (m, 5H, aryl-
H), 7.2-7.3 (m, 2H, aryl-H), 7.76 (s, 2H, aldimine-H). 13C NMR
(C6D6, 50.3 MHz): δ 17.40, 21.38, 24.84, 33.64, 63.17, 71.58,
113.84, 116.73, 125.68, 129.33, 132.00, 133.81, 135.20, 169.18,
170.48. IR (KBr, disk): ν˜ ) 3422 (w) [v(H-O-H)], 2966, 2896
(m), 2366, 1846, 1812, 1736 (w), 1614, 1550, 1465, 1415 (s), 1350,
1342 (w), 1326 (m), 1242, 1219, 1182, 1144, 1089 (m), 1040, 992,
1
53.65; H, 6.17; N, 7.15. Found: C, 53.37; H, 6.18; N, 7.23. H
NMR (C6D6, 200 MHz): δ 1.14 (d, J ) 6.53 Hz, 12H, CH(CH3)2),
1.24 (s, 18H, C(CH3)3), 2.11 (s, 3H, CH3-toluene), 3.02 (sept, J )
6.54 Hz, 2H, CH(CH3)2), 6.74 (d, J ) 9.65 Hz, 2H, Aryl-3H,),
7.0-7.2 (m, 5H, toluene-H), 7.26 (s, 2H, aldimine-H), 7.86 (d, J
) 3.11 Hz, 2H, aryl-6H), 7.98 (dd, J ) 9.65, 3.11 Hz, 2H, aryl-
4H). 13C NMR (C6D6, 50.28 MHz): δ 21.25, 24.36, 33.57, 62.99,
71.75, 116.15, 124.00, 125.71, 128.54, 129.33, 130.00, 136.69,
168.59, 175.74. IR (KBr): ν˜ ) 2968 (m), 2359 (w), 1625, 1604
(s), 1550 (m), 1508 (w), 1490 (m), 1438 (w), 1417, 1358 (m), 1317
(s), 1247, 1194, 1144, 1130, 1105 (m), 1033, 1000 (w), 948, 930
971 (w), 936 (s), 870 (w), 752 (s), 723, 628 (w), 594 (s) cm-1
.
X-ray analysis of the crystals revealed that the complex exits as a
µ-t-butoxide-bridged dimer with two toluene molecules per dimer
unit (one per metal atom) in the solid state.
(m), 842, 788, 762, 742, 690, 652, 590, 512 cm-1
.
(3Mesal)2Zn‚Toluene (2a‚Toluene). Zinc acetate dihydrate (436
mg, 2 mmol) was added to a solution of 3-methylsalicylaldimine
(709 mg, 4 mmol) in 20 mL of methanol and refluxed for 16 h.
The resulting yellow solution was cooled to 5 °C. The precipitate
formed was filtered and dried in a vacuum to give 660 mg (79%)
of yellow block-shaped crystals of the desired bis-salicylaldiminato
complex of zinc. Anal. Calcd for C22H28N2O2Zn: C, 63.24; H, 6.75;
[(5Me-sal)Zn(µ-OtBu)]2‚thf (1b‚thf). The complex 1b‚thf was
prepared according to the general procedure (75%). Anal. Calcd
for (C15H23NO2Zn)2: C, 57.24; H, 7.37; N, 4.45. Found: C, 56.77;
H, 7.00; N, 5.05. 1H NMR (C6D6, 300 MHz): δ 1.28 (d, J ) 6.64
Hz, 12H, CH(CH3)2), 1.41 (s, 18H, C(CH3)3), 2.14 (s, 6H, 5-CH3),
3.17 (sept, J ) 6.64 Hz, 2H, CH(CH3)2), 3.57 (traces THF), 6.65
(d, J ) 2.49 Hz, 2H, Aryl-3H), 7.01 (dd, J ) 8.72, 2.49 Hz, 2H,
Aryl-4H), 7.23 (d, J ) 8.72 Hz, 2H, Aryl-6H), 7.72 (s, 2H,
aldimine-H). 13C NMR (C6D6, 75.45 MHz): δ 20.24, 24.90, 25.83
(THF), 33.90, 62.97, 67.83 (THF), 71.53, 110.02, 117.30, 122.22,
124.19, 135.28, 136.83, 169.01, 170.45. IR (CH2CL2): ν˜ ) 3055
(s), 2975, 2360, 2305, 1758 (w), 1621 (s), 1534, 1458, 1474, 1421
(m), 1398, 1369, 1316, 1211, 1154, 1134, 1104 (m), 1063 (w),
896 (s), 831, 806 (w) cm-1. Block-shaped, slightly yellow crystals
suitable for X-ray analysis were obtained at -20 °C from THF/
hexane after 2 days. The X-ray analysis revealed that the complex
exists as a µ-t-butoxide-bridged dimer with one molecule of THF
in the solid state.
1
N, 6.70. Found: C, 63.20; H, 6.94; N, 6.63. H NMR (C6D6, 200
MHz): δ 0.82, 1.10 (2d, J ) 6.23 Hz, 12H, CH(CH3)2), 2.47 (s,
6H, 3-CH3), 2.91 (sept, J ) 6.23 Hz, 2H, CH(CH3)2), 6.58 (“t”,
2H, Aryl-H), 6.84 (dd, 2H, aryl-H), 7.26 (dd, 2H, aryl-H), 7.66 (s,
2H, aldimine-H). 13C NMR (C6D6, 75.45 MHz): δ 17.38, 23.38,
24.56, 62.87, 113.96, 117.34, 131.80, 133.99, 135.28, 169.26,
170.13. IR (KBr, disk): ν˜ ) 2962, 2915, 2359 (m), 1613, 1547,
1458, 1425, 1406 (s), 1368, 1316 (w), 1264, 1217, 11421, 1090
(m), 1033, 962 (w), 863 (w), 797, 750 (s), 722 (w) cm-1. X-ray
analysis of the crystals from toluene revealed that the complex exists
as a four coordinate monomer with distorted tetrahedral geometry
and one molecule of toluene in the solid state.
Inorganic Chemistry, Vol. 43, No. 10, 2004 3165